摘要 |
<p>Medicines having inhibitory activity against the activation of NF-kB, which contain as the active ingredient compounds represented by the general formula (I)(wherein X is a connecting group; A is hydrogen or acetyl; E is aryl or heteroaryl; and Z is arene or heteroarene) or pharmacologically acceptable salts thereof: (I)</p> |